Related Experiment Video
Updated: Sep 7, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
miRNA-486-5p: signaling targets and role in non-malignant disease
Adrianna Douvris1,2, Jose Viñas1, Kevin D Burns3,4
1Division of Nephrology, Department of Medicine and Kidney Research Centre, The Ottawa Hospital Research Institute, University of Ottawa, 1967 Riverside Dr., Rm. 535, Ottawa, ON, K1H 7W9, Canada.
Abstract:
MicroRNAs (miRNAs) are short non-coding RNAs, highly conserved between species, that are powerful regulators of gene expression. Aberrant expression of miRNAs alters biological processes and pathways linked to human disease. miR-486-5p is a muscle-enriched miRNA localized to the cytoplasm and nucleus, and is highly abundant in human plasma and enriched in small extracellular vesicles. Studies of malignant and non-malignant diseases, including kidney diseases, have found correlations with circulating miR-486-5p levels, supporting its role as a potential biomarker. Pre-clinical studies of non-malignant diseases have identified miR-486-5p targets that regulate major signaling pathways involved in cellular proliferation, migration, angiogenesis, and apoptosis. Validated miR-486-5p targets include phosphatase and tensin homolog (PTEN) and FoXO1, whose suppression activates phosphatidyl inositol-3-kinase (PI3K)/Akt signaling. Targeting of Smad1/2/4 and IGF-1 by miR-486-5p inhibits transforming growth factor (TGF)-β and insulin-like growth factor-1 (IGF-1) signaling, respectively. Other miR-486-5p targets include matrix metalloproteinase-19 (MMP-19), Sp5, histone acetyltransferase 1 (HAT1), and nuclear factor of activated T cells-5 (NFAT5). In this review, we examine the biogenesis, regulation, validated gene targets and biological effects of miR-486-5p in non-malignant diseases.
Insights
MicroRNAs (miRNAs), like miR-486-5p, regulate gene expression and are implicated in disease. This review explores miR-486-5p
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression, with aberrant levels linked to human diseases.
- miR-486-5p, a muscle-enriched miRNA, is abundant in plasma and extracellular vesicles, showing potential as a disease biomarker.
- Its dysregulation is observed in various conditions, including kidney diseases.
Purpose of the Study:
- To review the biogenesis and regulation of miR-486-5p.
- To identify and discuss validated gene targets of miR-486-5p.
- To examine the biological effects of miR-486-5p in non-malignant diseases.
Main Methods:
- Literature review of pre-clinical and clinical studies.
- Analysis of miRNA biogenesis and regulatory mechanisms.
- Identification and validation of miR-486-5p gene targets and their associated signaling pathways.
Main Results:
- miR-486-5p targets include PTEN, FoXO1, Smad1/2/4, IGF-1, MMP-19, Sp5, HAT1, and NFAT5.
- Suppression of PTEN and FoXO1 by miR-486-5p activates PI3K/Akt signaling.
- Inhibition of TGF-β and IGF-1 signaling by miR-486-5p targeting Smad1/2/4 and IGF-1, respectively.
Conclusions:
- miR-486-5p plays a significant role in regulating cellular processes like proliferation, migration, angiogenesis, and apoptosis.
- Validated targets of miR-486-5p provide insights into its function in non-malignant diseases.
- Further research into miR-486-5p's biological effects can enhance its potential as a diagnostic and therapeutic target.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
Non-Canonical Wnt Signaling Pathways

